Acute GFAP and NfL suppression among symptomatic participants was surprising, and may appear to be contrary to the effects shown for concussed athletes, wherein biomarkers generally increase among cohorts with a clinically defined concussion [32]. The gene discussed is NEFL; the disease is brain injury.